INVST’s T2 Biosystems, Inc TTOO Stock Holding History

INVST’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-350	Closed	-$7.73K	–	225
2023 Q3	$7.73K	Buy	+350	New	+$9.13K	﹤0.01%	191

Other funds holding TTOO

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

INVST's TTOO Position: Q4 2023 in Review

INVST sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 350 shares — an estimated $7.73K sold.

INVST first reported a position in TTOO in Q3 2023 and held it in 1 quarter. The position peaked at $7.73K in Q3 2023. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

INVST reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
INVST sold 350 T2 Biosystems, Inc shares in Q4 2023, an estimated $7.73K.
INVST first reported a position in T2 Biosystems, Inc in Q3 2023 and held it in 1 quarter.
INVST's T2 Biosystems, Inc position peaked at $7.73K in Q3 2023.
21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on INVST's 13F filing for Q4 2023, filed 7 Feb 2024.